Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evacetrapib in Japanese Patients With Primary Hypercholesterolemia
jRCT2080222669Phase 3
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypercholesterolemia comparing Evacetrapib → Evacetrapib open-label with Placebo → Evacetrapib open-label (2 arms).
02
Drugs
evacetrapib
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on jRCT2080222669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222669.